Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Data Brief: Healthcare Utilization for Vaso-Occlusive Episodes by People with Sickle Cell Disease in California and Georgia, 2015
source: Centers for Disease Control and Prevention
year: 2020
summary/abstract:Many people with sickle cell disease (SCD) had a hospitalization or an emergency department (ED) visit with a vaso-occlusive episode (VOE), or pain crisis, diagnosis code.
People with SCD:
• Go to the hospital more than once a year, with an average stay of 5 days per hospitalization.
• Go to the ED an average of 2–3 times a year.
• Go to the ED and hospital most commonly for VOEs.
More than 4 in 10 (41%) ED visits and more than 7 in 10 (73%) hospital admissions for people with SCD in California had a VOE diagnosis code.
Nearly 1 in 2 (48%) ED visits and 3 in 4 (75%) hospital admissions for people with SCD in Georgia had a VOE diagnosis code.
read more
+myBinderRelated Content
-
Representative Johnson Files Four Sickle Cell Disease Related BillsState Representative Jarvis Johnson (HD ...
-
The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emer...Background: Sickle cell anaemia (SCA) i...
-
Sickle Cell Disease in the Emergency Department: Confronting Barriers to Care“You’re too pretty to have a disease...
-
University of Illinois at Chicago awarded $4.6 million NIH grant for chronic pain researchThe University of Illinois at Chicago ha...
-
Lower Airway Obstruction Is Associated with Increased Vaso-Occlusive Pain Episodes in Adults with Sickle Cell AnemiaBackground: Vaso-occlusive pain episodes...
-
10th Annual Walk with the Stars – Sickle Cell Disease Association of America, Inc.When: September 16, 2023 Where: Rash Fi...
-
Smartphone App May Help Assess Anemia Using Eyelid PicturesA smartphone app that measures hemoglobi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.